Anemia of Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Anemia of Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia [Phase 2]
Phase 2 dose‑response study evaluating the safety and efficacy of GSK1278863 (daprodustat) for anemia in hemodialysis-dependent patients wit…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia [Phase 2]
Phase 2 trial update showing results for intravenous Mircera in hemodialysis patients with anemia due to chronic kidney disease; results pos…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis [Phase 1]
A Phase 1 mass balance study evaluating JTZ-951 in subjects with end-stage renal disease on hemodialysis has been completed, in the context …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia. [Phase 3]
Phase 3 trial comparing Mircera given every four weeks to epoetin beta in dialysis patients with anemia due to chronic kidney disease, asses…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients [Phase 3]
Phase 3 trial evaluating intravenous or subcutaneous Mircera for anemia in dialysis patients has completed; this entry provides a trial resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia. [Phase 4]
Phase 4 crossover trial comparing NeoRecormon (epoetin beta) and darbepoetin alfa in patients with anemia due to chronic kidney disease to e…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical Practice
This is a completed observational study evaluating Mircera for correcting renal anemia in dialysis patients during routine clinical practice…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis [Phase 3]
Phase 3 clinical trial update showing completion of a study evaluating Mircera for treatment of anemia in patients with chronic kidney disea…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis [Phase 3]
Phase 3 trial update showing completion and posted results for subcutaneous Mircera given monthly to treat anemia in adults with chronic kid…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia [Phase 3]
A Phase 3 study evaluating once-monthly subcutaneous Mircera (methoxy polyethylene glycol-epoetin beta) for anemia in dialysis patients with…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia [Phase 4]
Phase 4 trial results update for subcutaneous Mircera used as maintenance therapy in anemia of chronic kidney disease; results posted.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia [Phase 3]
This clinical trial update reports results from a Phase 3 study of intravenous Mircera in hemodialysis patients with chronic renal anemia.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients. [Phase 3]
Phase 3 trial evaluating intravenous Mircera (methoxy polyethylene glycol-epoetin beta) for correcting anemia in dialysis patients has compl…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: A Study of Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy. [Phase 4]
A Phase 4 study evaluating Mircera given every two weeks for dialysis patients with chronic renal anemia not previously treated with ESAs ha…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Stage III-IV Chronic Kidney Disease Patients Not on Dialysis With Renal Anemia
An observational study evaluating Mircera (methoxy polyethylene glycol-epoetin beta) in stage III–IV chronic kidney disease patients not on …
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal Anemia [Phase 3]
A Phase 3 trial evaluating subcutaneous C.E.R.A. (methoxy polyethylene glycol-epoetin beta) in pre-dialysis patients with anemia of chronic …
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia [Phase 3]
Phase 3 results update for Mircera in adults with anemia due to chronic kidney disease undergoing hemodialysis; the trial has completed and …
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia [Phase 4]
Phase 4 study evaluating monthly methoxy polyethylene glycol-epoetin beta for anemia of chronic kidney disease was terminated; results were …
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. [Phase 3]
Phase 3 trial LATINO evaluating Mircera for maintenance treatment of anemia in dialysis patients with chronic kidney disease completed, with…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease [Phase 1]
Phase 1 study completed to evaluate the pharmacokinetic interaction between lapatinib and JTZ-951 in subjects with end-stage renal disease d…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia. [Phase 3]
Phase 3 trial results for subcutaneous Mircera in maintenance treatment of anemia in dialysis patients with chronic kidney disease; the stud…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating monthly intravenous C.E.R.A. (Mircera) in hemodialysis patie…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia [Phase 3]
A Phase 3 trial of Mircera for maintenance treatment of anemia in chronic kidney disease has completed. Results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients [Phase 3]
Phase 3 trial results have been posted for intravenous Mircera in the treatment of anemia in dialysis patients.
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. [Phase 3]
Phase 3 trial evaluating intravenous Mircera for anemia in dialysis patients has completed, with results posted in 2016.